ISPECIMEN INC (ISPC)
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-11-04
$0.84+6.75%
Close 2026-11-04 · 1-day change
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-11-04
QuarterlyIQ Insights · ISPC
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -49.9% |
| Our one-year growth estimate | diamond | -60.0% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 10.1 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Elevated risk of a next-quarter earnings miss: this name is a smaller-cap name (higher miss base rate) and has been missing across recent quarters. A fundamental tilt, not a price call.
Model as of 2026-11-04 · Compared with 13 industry peers
ISPC — legal / regulatory event — Notice of Delisting or Failure to
Dated 2026-09-10
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On September 8, 2026, iSpecimen Inc. (the “Company”) received a letter dated September 8, 2026 (the “Deficiency Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it had been granted an extension of time to regain compliance with Nasdaq Listing Rule 5550(b) (the “Rule”). On May 29, 2026, Nasdaq first notified the Company tha…
Why it matters: The deal adds AI software assets, but the inputs give no revenue or cost data. A clear use in the marketplace would show progress.
Supportive ifA company filing or earnings update confirms the Foldlab asset purchase closed. It names a product use or customer launch date.
Worry ifA filing says the deal ended, failed to close, or the assets have no stated product use in the next earnings update.
Why it matters: The company has raised money for working capital and to repay liabilities. Its signal set still marks it as loss-making.
Watch forThe Nov. 16 update reports lower cash use and smaller operating losses than the prior reported period.
Also watch forThe Nov. 16 update reports higher cash use, larger operating losses, or a need for more capital.
Why it matters: The split aimed to help meet Nasdaq's minimum bid rule. The later Nasdaq notice shows listing concerns remain.
Worry ifA Nasdaq notice confirms the company meets the minimum bid rule and keeps its listing in good standing.
Less concerning ifA Nasdaq notice cites a new minimum bid failure or further listing trouble after the split.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$320 on $10,000 · ±3.2% | How much price usually moves either way. |
| Bad day | $1,139 loss on $10,000 · 11.4% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $9,707 loss on $10,000 · 97.1% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.